Illustrative estimate only - not verified by this sponsor. Contact the study team for actual compensation.
The purpose of this research study is to investigate whether tDCS to the cerebellum (specifically, the right crus I/II area of the cerebellum) of children and young adults with autism spectrum disorders (ASD) is safe and to examine its effects on some of the symptoms of ASD, such as repetitive behaviors and hyperactivity.
What happens when you apply
Reach out via phone or email to express interest
Brief call to discuss your health history
Medical screening at the research site
Begin your journey in the study
Inclusion Criteria: * 4-17 years old * Diagnosed with ASD and ADOS-2 * IQ Score no less than 70 (1.5 Standard Deviations below the mean) * Language Level (Speech consists of, at minimum, flexible, spontaneous, simple, sentences) Exclusion Criteria: * Brain implants, metal implants, pacemakers, or biomedical devices * Diagnosis of epilepsy * Hearing or visual impairments * History of brain injury * Known brain abnormalities not associated with ASD
imaguineapig pulls live data from ClinicalTrials.gov (NIH/NLM).Illustrative estimate only - not verifiedPay estimates are approximate ranges based on study type and are not confirmed by sponsors — actual compensation may differ. Eligibility indicators use limited criteria (age, sex) only. We do not provide medical advice. Always contact the study team directly to confirm compensation, full eligibility, and risks before enrolling.